Latest Price Spikes News

Micro-X has told ASX it is unaware of any undisclosed information explaining the sharp move in its shares, which rose from $0.030 to $0.045 during 23 September trading. The company pointed to elevated volumes, earlier institutional selling and chairman Patrick O’Brien’s purchase of 1.36 million shares.

Bridge SaaS has told ASX it knows of no undisclosed information behind a sharp share price fall and significant increase in trading volume. The response confirms compliance with continuous disclosure rules but leaves the market activity unexplained.

Pan African Resources delivered record FY26 production, earnings and cash generation, moving from net debt to a US$185.7 million net cash position. The gold producer is proposing a record dividend and launching a ZAR500 million buy-back, while warning that FY27 costs will rise as it funds further growth.

Venari Minerals says it knows of no undisclosed information behind a sharp rise in its share price and trading volume. The company points instead to ongoing Red Mountain drilling and a proposed exploration program still awaiting US regulatory approval.

Alara Resources has told ASX it knows of no undisclosed information behind a sharp rise in its share price and trading volume. The company said its response was approved by Executive Chair Peter Lee and confirmed compliance with continuous disclosure rules.

Mount Ridley Mines has told ASX it holds no unreleased exploration results that explain its share price rise, while confirming three testwork programs remain in progress. The company also disclosed that an institutional investor had approached it about participating in its current capital raising.

Leeuwin Metals has rejected the possibility of undisclosed exploration results driving a sharp rise in its share price, after ASX queried the move from $0.22 to $0.295. The gold explorer pointed instead to recent Marda news, a company-funded research report, stronger gold prices and buying by a substantial holder.

Revolver Resources says it knows of no undisclosed information behind a sharp rise in its shares and trading volume. The company pointed only to ongoing work at the Dianne Copper Mine and progress towards a positive Final Investment Decision.

Actinogen Medical (ASX:ACW) has clarified that no undisclosed information explains recent unusual trading in its shares, pointing instead to recent underwriting of options and published updates. The biotech also reaffirmed compliance with ASX rules and provided a detailed update on its lead Alzheimer’s drug Xanamem and ongoing clinical trials.

Farm Pride Foods Ltd reported a 16% revenue increase to $118.3 million and a 53% jump in net profit to $10.2 million for FY26, underpinned by operational improvements and strategic capital investments.

Bisalloy Steel’s FY26 profit fell 16% as softer domestic demand and Indonesian import restrictions weighed, but the company secured a pioneering US submarine steel order and advanced its digital wear-monitoring technology.

Elevra Lithium posted a $44 million profit in FY26 after merging Sayona Mining and Piedmont Lithium, overcoming temporary mining challenges and securing full funding for the North American Lithium expansion.